Alpha Tau Medical (DRTS) vs SI-BONE (SIBN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Alpha Tau Medical (DRTS) has outperformed SI-BONE (SIBN) over the past year, gaining 207.7% versus a gain of 21.7%. Over five years, SIBN leads with a +18.5% price change compared with +18.5% for DRTS. Alpha Tau Medical is the larger company by market cap ($1.09 billion vs $1.07 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRTS | SIBN |
|---|---|---|
| Share price | $11.76 | $23.73 |
| Market cap | $1.09B | $1.07B |
| 1-day change | +3.93% | -0.08% |
| YTD return | +137.47% | +20.33% |
| 1-year return | +207.72% | +21.69% |
| 5-year return | +18.50% | +18.53% |
| EPS (TTM) | $-1.04 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $200.93M |
| Revenue growth (YoY) | — | +20.19% |
| Net income (latest FY) | $-42.63M | $-18.90M |
| Gross margin | — | 79.57% |
| Operating margin | — | -11.11% |
| Net margin | — | -9.41% |
| 52-week high | $15.79 | $25.92 |
| 52-week low | $3.65 | $11.48 |
| Distance from 52-week high | -25.55% | -8.45% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +75.24% | +12.85% |
| Average volume | 591.88K | 709.79K |
| Shares outstanding | 92.48M | 45.11M |
| Employees | 121 | 376 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DRTS has outperformed SIBN by 186.0 percentage points over the past year.
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Health Care · Medical/Dental Instruments · 121 employees
About SI-BONE
SIBN stock →SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
Health Care · Medical/Dental Instruments · 376 employees
DRTS vs SIBN FAQ
Which is bigger, Alpha Tau Medical or SI-BONE?
Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.09B compared with $1.07B for SI-BONE (SIBN).
Which stock has performed better over the past year, DRTS or SIBN?
DRTS returned +207.72% over the past 12 months, compared with +21.69% for SIBN (price return, excluding dividends). Past performance does not predict future results.
Are Alpha Tau Medical and SI-BONE in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.